The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kelly-Welch, A. E.
Right arrow Articles by Keegan, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kelly-Welch, A. E.
Right arrow Articles by Keegan, A. D.
The Journal of Immunology, 2004, 172: 2803-2810.
Copyright © 2004 by The American Association of Immunologists

Transgenic Expression of Insulin Receptor Substrate 2 in Murine B Cells Alters the Cell Density-Dependence of IgE Production In Vitro and Enhances IgE Production In Vivo1

Ann E. Kelly-Welch*, Helen Y. Wang*, Ling-Mei Wang{dagger}, Jacalyn H. Pierce{dagger}, Gilbert Jay*, Fred Finkelman{ddagger} and Achsah D. Keegan2,*

* Department of Immunology, Jerome Holland Laboratories, American Red Cross, Rockville, MD 20855; {dagger} Laboratory of Cellular and Molecular Biology, National Cancer Institute, Bethesda, MD 20892; and {ddagger} University of Cincinnati, Children’s Research Hospital, Cincinnati, OH 45267

Previous studies have shown that insulin receptor substrate (IRS)1 and IRS2 mediate proliferative and antiapoptotic signaling through the IL-4R in 32D cells; however their role in regulating normal B cell responses is not clear. To investigate the role of IRS2 in normal B cell function, we developed IRS2 transgenic (Tg) mice on the C57BL/6 background. Western blot analysis revealed a 2-fold elevation in IRS2 protein levels in Tg+ mice compared with littermate controls and a 3-fold increase in basal tyrosine phosphorylated IRS2 in the absence of IL-4 stimulation. IL-4-induced tyrosine phosphorylation of IRS2 was elevated in Tg+ B cells, whereas IL-4-induced phosphorylation of STAT6 was similar between Tg+ and Tg- B cells. Tg expression of IRS2 had little effect on IL-4-mediated proliferation and no effect on protection from apoptosis. However, production of IgE and IgG1 by Tg+ B cells using standard in vitro conditions was diminished 50–60%. Because Ig production in vitro is known to be highly cell concentration-dependent, we performed experiments at different cell concentrations. Interestingly, at very low B cell concentrations (1000–5000 B cells/well), IgE and IgG1 production by Tg+ B cells was greater than that of controls, whereas at higher cell concentrations (10,000–20,000 cells/well) Ig production by Tg+ B cells was less than controls. Furthermore, in vivo immunization with OVA-alum or goat anti-IgD resulted in elevated serum IgE levels in the Tg+ mice. These results indicate that overexpression of IRS2 alters the B cell intrinsic density-dependence of IgE and IgG1 production in vitro and enhances IgE responses in vivo.




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
V. T. Thieu, E. T. Nguyen, B. P. McCarthy, H. A. Bruns, R. Kapur, C.-H. Chang, and M. H. Kaplan
IL-4-stimulated NF-{kappa}B activity is required for Stat6 DNA binding
J. Leukoc. Biol., August 1, 2007; 82(2): 370 - 379.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Baudler, J. Baumgartl, B. Hampel, T. Buch, A. Waisman, C. M. Snapper, W. Krone, and J. C. Bruning
Insulin-Like Growth Factor-1 Controls Type 2 T Cell-Independent B Cell Response
J. Immunol., May 1, 2005; 174(9): 5516 - 5525.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.